BIOFORCE NANOSCIENCES HLD vs. Alphabet Inc. Class C Capital Stock
BFNH
BIOFORCE NANOSCIENCES HLD
$3.90 +6.79%
VS GOOGAlphabet Inc. Class C Capital Stock
$347.17 +1.59%
BIOFORCE NANOSCIENCES HLD and Alphabet Inc. Class C Capital Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| BFNH | GOOG | |
|---|---|---|
| Market Cap | — | $4.18 trillion |
| Revenue (TTM) | — | $445.87 billion |
| Net Income (TTM) | — | $244.21 billion |
BFNH and GOOG split the size & scale factors evenly.
Valuation
| BFNH | GOOG | |
|---|---|---|
| P/E Ratio | — | 17.42 |
| Price / Book | — | 6.53 |
| Price / Sales | — | 9.37 |
BFNH and GOOG split the valuation factors evenly.
Profitability
| BFNH | GOOG | |
|---|---|---|
| Net Margin | — | 54.77% |
| Return on Equity | — | 38.13% |
BFNH and GOOG split the profitability factors evenly.
Dividend
| BFNH | GOOG | |
|---|---|---|
| Dividend Yield | — | 0.25% |
| Payout Ratio | — | 4.42 |
BFNH and GOOG split the dividend factors evenly.
Risk & Sentiment
| BFNH | GOOG | |
|---|---|---|
| Short Interest | — | 0.07% |
BFNH and GOOG split the risk & sentiment factors evenly.
Dig deeper: BFNH overview, BFNH financials, GOOG overview, GOOG financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.